- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02285595
Sonendo GentleWave™ System for Treatment in Molar Teeth Requiring Root Canal Therapy (SUPREME)
A Prospective, Multicenter Study Comparing Healing After Treatment With the Sonendo GentleWave™ System as Compared to a Traditional Root Canal Therapy Literature Control
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
California
-
Aliso Viejo, California, United States
- Shahriar Rassoulian, DMD
-
Santa Ana, California, United States
- Khang Le, DDS
-
Whittier, California, United States
- Stacey Woo, DDS
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 18 to 75 years of age
- Indicated for root canal therapy
- First or second molar
- Signed informed consent form
Exclusion Criteria:
- Poor oral hygiene
- Class II or III mobility
- Open or incompletely formed root apices
- Vertical fracture, horizontal fracture, or perforation below the Cemento-Enamel Junction (CEJ)
- Previous pulpectomy or root canal therapy
Note: Additional exclusion criteria may apply.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Sonendo GentleWave™ System
The Sonendo GentleWave System is intended to prepare, clean, and irrigate 1st and 2nd molar teeth indicated for root canal therapy.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Subject teeth that are healed or healing at the 12 month follow-up visit.
Time Frame: 12 months
|
Healed is defined by absence of a radiographic indication of apical periodontitis (PAI <3) and absence of clinical signs and symptoms other than tenderness to percussion. Healing is defined by a reduction of radiolucency (if radiolucency is present at Baseline) combined with the absence of clinical signs and symptoms other than tenderness to percussion. |
12 months
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Dan Miller, Sonendo, Inc.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- CS-06
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.